معرفی
Yingjun Cui is an Associate Research Scientist in the Department of Internal Medicine, Infectious Diseases at Yale School of Medicine. His research program focuses on vector biology and vector-borne diseases, with particular expertise in mosquito and tick biology and their transmitted pathogens including Lyme disease, Zika virus, Chikungunya fever, and malaria.
His research interests span vector-pathogen-host interactions, employing methodologies from entomology, molecular biology, microbiology, and omics technologies to develop novel anti-vector strategies for controlling emerging and reemerging vector-borne diseases. His work particularly emphasizes understanding the molecular and cellular mechanisms underlying vector competence, pathogen transmission, and host immune responses to vector feeding.
Dr. Cui's recent publications reveal a strong focus on cutting-edge approaches to vector control, including mRNA vaccine development targeting tick proteins, single-cell analysis of vector tissues, and comprehensive studies of vector-pathogen interactions. His research bridges basic science with translational applications, aiming to develop novel interventions against vector-borne diseases that affect millions worldwide.
Dr. Cui has established productive collaborations with leading researchers in the field, most notably with Dr. Erol Fikrig's laboratory at Yale, with whom he has co-authored numerous high-impact publications in journals such as Cell, Science Translational Medicine, and Nature Vaccines. His work demonstrates a consistent trajectory of high-quality research addressing critical challenges in vector-borne disease prevention and control.
